Product NDC: | 51672-4107 |
Proprietary Name: | Oxcarbazepine |
Non Proprietary Name: | Oxcarbazepine |
Active Ingredient(s): | 600 mg/1 & nbsp; Oxcarbazepine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4107 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077801 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071115 |
Package NDC: | 51672-4107-0 |
Package Description: | 10 BLISTER PACK in 1 CARTON (51672-4107-0) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 51672-4107-0 |
Proprietary Name | Oxcarbazepine |
Package Description | 10 BLISTER PACK in 1 CARTON (51672-4107-0) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 51672-4107 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxcarbazepine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071115 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | OXCARBAZEPINE |
Strength Number | 600 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |